Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06793072 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adipokines in Polycystic Ovary Syndrome

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Dec 31, 2025 to Dec 31, 2027
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    v4
  2. Minor Re-verified, no change to tracked fieldsv3
  3. Minor Study title expanded, about 2 wordsv2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to compare the concentrations of leptin, resistin, and omentin-1 in women across three research groups: those with polycystic ovary syndrome without insulin resistance, those with polycystic ovary syndrome with insulin resistance, and women without polycystic ovary syndrome.
Trial Details
NCT Number NCT06793072
Lead Sponsor Jagiellonian University
Conditions
(from sponsor)
PCOS, Reproductive Age
Related terms Insulin Resistance, Metabolic Syndrome, Polycystic Ovary Syndrome
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov